-
Tonix Pharmaceuticals Presented Phase 3 RESILIENT Data on TONMYA™ (Cyclobenzaprine HCl Sublingual Tablets) at the 2026 Non-Opioid Pain Therapeutics Summit
30 Jan 2026 12:00 GMT
… Pharmaceuticals Holding Corp.*
Tonix is a fully-integrated biotechnology … prescription medicine approved by the FDA for … treatment initiation or dosage increases. Tricyclic antidepressant-like adverse reactions: Cyclobenzaprine … in the clinical trials in adult …
-
UR Medicine provides guidance on medication safety during pregnancy
30 Jan 2026 03:07 GMT
… remedies containing alcohol.
Certain drugs fall into a middle category requiring close medical … supervision—such as narcotics and prescription muscle relaxants like Flexeril … provider for testing and possible treatment is recommended.
Fever requires …
-
WellSpan denies liability in opioid-related medical negligence lawsuit
09 Jan 2026 17:38 GMT
… Chambersburg Hospital for rehab following treatment. That’s where Stanton … Health, WellSpan Medical Group and Stanton Sollenberger, the doctor accused of prescribing … an opioid; and Methocarbamol and Flexeril, muscle relaxers.
Sollenberger noted Knott …
-
Tonix Pharmaceuticals to Present at Two Investor Conferences in January 2026
06 Jan 2026 12:00 GMT
… Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals is a fully-integrated biotechnology … treatment initiation or dosage increases.
Tricyclic antidepressant-like adverse reactions: Cyclobenzaprine … clinical trials in … Medicines, Inc. at 1-888-869-7633, or the FDA …
-
Pa. man charged with homicide in drug death case pleads to reduced charge
06 Jan 2026 23:28 GMT
… with homicide in a drug death that a coroner … could be obtained at a trial, he said.
County Judge … be mixed drug toxicity, including cocaine, hydroxyzine, citalopram, and cyclobenzaprine.
Deputy … facing trial on charges of third-degree murder, drug delivery …
-
FDA Drug Approvals Q3 2025
06 Jan 2026 17:43 GMT
… received a BCMA antibody-drug conjugate. J Clin Oncol … -label, nonrandomized clinical trials that evaluated adults and … no longer as adjunct to statin therapy)
Repatha (evolocumab)— … 18 months of IV treatment
Tonmya (cyclobenzaprine)— New sublingual dosage …
-
Steve Cohen's Point72 Buys $20M of Biotech Stock Advancing Depression Treatment
05 Jan 2026 12:47 GMT
… 2025, Point72 added Tonix Pharmaceuticals (Nasdaq: TNXP) to … Drug (IND) application for the clinical development of cyclobenzaprine … adults. This FDA clearance allows the emerging biotech firm to … a best-in-class treatment,'; Lederman added.
In …
-
Tonix Pharmaceuticals Announces Pricing of $20.0 Million Registered Direct Offering
29 Dec 2025 12:57 GMT
… Pharmaceuticals Holding Corp.*
Tonix is a fully-integrated biotechnology … analgesic medicine for the treatment of … treatment initiation or dosage increases. Tricyclic antidepressant-like adverse reactions: Cyclobenzaprine … drugs to the FDA. Visit www.fda. …
-
Tonix Pharmaceuticals Announces Program Updates on Phase 2/3-Ready Long-Acting Monoclonal Antibody (mAb) Designed for Seasonal Prevention of Lyme Disease (TNX-4800)
29 Dec 2025 12:45 GMT
… Pharmaceuticals Holding Corp.*
Tonix Pharmaceuticals is a fully-integrated biotechnology … medicine for the treatment … treatment initiation or dosage increases.
Tricyclic antidepressant-like adverse reactions: Cyclobenzaprine … drugs to the FDA. Visit www.fda …
-
Tonix Pharmaceuticals Announces FDA IND Clearance for Phase 2 Study of TNX-102 SL for the Treatment of Major Depressive Disorder
24 Nov 2025 12:00 GMT
… biotechnology company, today announced the U.S. Food and Drug Administration (FDA … Chief Medical Officer of Tonix Pharmaceuticals. … treatment initiation or dosage increases.
Tricyclic antidepressant-like adverse reactions: Cyclobenzaprine … clinical trials in …
About
© 1995-2026